Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
A Phase I/II Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
† Study has passed its completion date and status has not been verified in more than two years.